We've been named one of the World's Most Admired Companies by Fortune magazine every year since 1984 and ranked No. 1 in our industry sector for six consecutive years (2014-2019).

We're listed No. 158 on the Forbes Global 2000 list of the world's largest companies, based on 2019 revenue.

Abbott's diagnostic blood test for the heart was featured among Fast Company's World Changing Ideas honorees.

We were recognized with a 2017 Chicago Innovation Award for a pioneering breakthrough in infant formula with Similac Pro-Advance and Pro-Sensitive with 2’-FL HMO. 

Continuous glucose monitor named Best Medical Technology as part of Galien Foundation's Prix Galien competition.

Abbott was named among the Top 10 businesses in biotech on Fast Company's 2017 list of most innovative companies.

Abbott has been included on DJSI for 17 consecutive years for strong environmental, social and governance (ESG) performance.

3BL Media named us among the top 100 companies for 14 consecutive years (2009-2022).

Fortune magazine included us on their 2020 “Change the World” list, which recognizes companies for delivering shared value by making positive social impacts through their core business.

We've been named one of The World's Most Admired Companies by Fortune since 1984 and ranked No. 1 in our industry sector for nine consecutive years (2014-2022).